Back to Search
Start Over
Boldine: a narrative review of the bioactive compound with versatile biological and pharmacological potential.
- Source :
- Journal of Complementary & Integrative Medicine; Sep2024, Vol. 21 Issue 3, p269-281, 13p
- Publication Year :
- 2024
-
Abstract
- Boldine is a plant-derived bioactive compound that has a beneficial impact on human health. Boldine is an aporphine alkaloid mainly obtained from the leaves and bark of the Chilean Boldo tree (Peumus boldus, Family: Monimiaceae). There are plenty of preclinical evidence supports that boldine exerts its beneficial effects against various diseases. Lumiskin™, a patented and marketed formulation by Revitol Skincare for skin brightening, contains Dicetyl boldine, a boldine derivative. All the available information on the Chilean boldo tree (P. boldus Molina) species was actualized by systematically searching the scientific databases (PubMed, SciFinder, Web of Science, Google Scholar, Scopus and others) and scientific literature. This article covers the recent advances in pharmacokinetic, toxicological, pharmacological/biological activities, and molecular mechanisms of the bioactive compound to understand health benefits of boldine better. Boldine exerts antioxidant, hepatoprotective, anti-atherosclerotic, anti-diabetic, analgesic, antipyretic, anti-inflammatory, anti-epileptic, neuroprotective, nephroprotective, anti-arthritis, anticancer and nootropic effects. Moreover, boldine exhibits its various pharmacological activities by altering antioxidant parameters (MDA, superoxide dismutase, glutathione), peroxynitrite, inflammatory markers apoptotic index, caspase-3, acetyl-cholinesterase, myeloperoxidase, TNF-α (Tumor necrosis factor-α), iNOS, Bcl-2-associated X protein (BAX), ACE-1(Angiotensin-converting enzyme-1), dopamine D2 receptors and nicotinic acetylcholine receptor. Boldine has the potential to modulate a variety of biological networks. Due to its versatile pharmacological effects reported in various experimental animals as well as in randomized clinical trials for the treatment of facial melasma and for treatment of urinary stone lithotripsy in children as a complementary phytotherapy; in the future, this compound might be developed as a novel drug for a different indication [ABSTRACT FROM AUTHOR]
- Subjects :
- ATHEROSCLEROSIS prevention
THERAPEUTIC use of alkaloids
ANTI-inflammatory agents
NEUROPROTECTIVE agents
HEPATOTOXICOLOGY
TOXICOLOGY
APOPTOSIS
ANTINEOPLASTIC agents
HYPOGLYCEMIC agents
PLANT extracts
MEDICINAL plants
MOLECULAR structure
ANTIOXIDANTS
ORGANIC compounds
NONOPIOID analgesics
TUMOR necrosis factors
Subjects
Details
- Language :
- English
- ISSN :
- 15533840
- Volume :
- 21
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Journal of Complementary & Integrative Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 180033843
- Full Text :
- https://doi.org/10.1515/jcim-2023-0224